Palvella Therapeutics (PVLA) Return on Invested Capital (2014 - 2019)
Palvella Therapeutics (PVLA) reported Return on Invested Capital of 0.02% for Q3 2019, down 2.0% year-over-year from 0.02% in Q3 2018, and down 9.73% quarter-over-quarter from 0.02% in Q2 2019.
Palvella Therapeutics (PVLA) Return on Invested Capital (2014 - 2019) Analysis & Trends
Palvella Therapeutics (PVLA) has 6 years of Return on Invested Capital data on file, last reported at 0.02% in Q3 2019.
- Return on Invested Capital for Q3 2019 came in at 0.02%, down 2.0% year-over-year; the trailing twelve-month figure through Sep 2019 was 0.02% (down 2.0% YoY), and the FY2020 annual result was 0.01%, changed N/A from the prior year.
- Return on Invested Capital declined to 0.02% in Q3 2019 per PVLA's latest filing, from 0.02% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.0% in Q2 2018 and troughed at 0.04% in Q3 2017.
- A 5-year average of 0.01% and a median of 0.01% in 2018 frame the typical range for Return on Invested Capital.
- The sharpest annual moves came in 2015 and 2017: Return on Invested Capital soared 1207 bps in 2015, then declined 2 bps in 2017.
- A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2015, then declined by 22 bps to 0.01% in 2016, then tumbled by 271 bps to 0.02% in 2017, then jumped by 65 bps to 0.01% in 2018, then sank by 183 bps to 0.02% in 2019.
- Business Quant data shows PVLA's Return on Invested Capital at 0.02% in Q3 2019, 0.02% in Q2 2019, and 0.01% in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.01% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -0.01% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Palvella Therapeutics | 1.49 Bn | 1.23 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -0.02% |
| Jun 30, 2019 | -0.02% |
| Mar 31, 2019 | -0.01% |
| Dec 31, 2018 | -0.01% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | -0.01% |
| Dec 31, 2017 | -0.02% |
| Sep 30, 2017 | -0.04% |
| Jun 30, 2017 | -0.02% |
| Mar 31, 2017 | -0.01% |
| Jun 30, 2016 | -0.01% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | -0.01% |
| Jun 30, 2015 | -0.01% |
| Mar 31, 2015 | -0.01% |
| Sep 30, 2014 | -8.09% |
| Jun 30, 2014 | -12.08% |
| Mar 31, 2014 | -0.02% |